121 related articles for article (PubMed ID: 3945122)
1. Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literature.
Gertz MA; Kyle RA
Mayo Clin Proc; 1986 Mar; 61(3):218-23. PubMed ID: 3945122
[TBL] [Abstract][Full Text] [Related]
2. Primary amyloidosis with unusual bone involvement: reversibility with melphalan, prednisone, and colchicine.
Schattner A; Varon D; Green L; Hurwitz N; Bentwich Z
Am J Med; 1989 Mar; 86(3):347-8. PubMed ID: 2919619
[No Abstract] [Full Text] [Related]
3. Objective response in amyloidosis treated with intermittent chemotherapy.
Farhangi M; Thakur VM; Durham JB
South Med J; 1984 Jun; 77(6):775-7. PubMed ID: 6729558
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.
Gertz MA; Lacy MQ; Lust JA; Greipp PR; Witzig TE; Kyle RA
J Clin Oncol; 1999 Jan; 17(1):262-7. PubMed ID: 10458241
[TBL] [Abstract][Full Text] [Related]
5. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine.
Kyle RA; Gertz MA; Greipp PR; Witzig TE; Lust JA; Lacy MQ; Therneau TM
N Engl J Med; 1997 Apr; 336(17):1202-7. PubMed ID: 9110907
[TBL] [Abstract][Full Text] [Related]
6. The successful treatment of primary amyloidosis with intermittent chemotherapy.
Bradstock K; Clancy R; Uther J; Basten A; Richards J
Aust N Z J Med; 1978 Apr; 8(2):176-9. PubMed ID: 277166
[TBL] [Abstract][Full Text] [Related]
7. Primary systemic amyloidosis: resolution of the nephrotic syndrome with melphalan and prednisone.
Kyle RA; Wagoner RD; Holley KE
Arch Intern Med; 1982 Aug; 142(8):1445-7. PubMed ID: 7103624
[TBL] [Abstract][Full Text] [Related]
8. Therapy of primary amyloidosis with melphalan and prednisone.
Schwartz RS; Cohen JR; Schrier SL
Arch Intern Med; 1979 Oct; 139(10):1144-7. PubMed ID: 485747
[TBL] [Abstract][Full Text] [Related]
9. [79 year old male with constitutional syndrome and hepatomegaly].
Rebollar Merino A; Otero S; Marabé G; Mesa Latorre J; De Miguel J
Rev Clin Esp; 2007 Feb; 207(2):97-9. PubMed ID: 17397574
[No Abstract] [Full Text] [Related]
10. Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine.
Kyle RA; Greipp PR; Garton JP; Gertz MA
Am J Med; 1985 Dec; 79(6):708-16. PubMed ID: 3934968
[TBL] [Abstract][Full Text] [Related]
11. Resolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome.
Cohen HJ; Lessin LS; Hallal J; Burkholder P
Ann Intern Med; 1975 Apr; 82(4):466-73. PubMed ID: 1119764
[TBL] [Abstract][Full Text] [Related]
12. Treatment of AL amyloidosis with melphalan, prednisone, and colchicine.
Benson MD
Arthritis Rheum; 1986 May; 29(5):683-7. PubMed ID: 3718560
[TBL] [Abstract][Full Text] [Related]
13. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.
Skinner M; Anderson J; Simms R; Falk R; Wang M; Libbey C; Jones LA; Cohen AS
Am J Med; 1996 Mar; 100(3):290-8. PubMed ID: 8629674
[TBL] [Abstract][Full Text] [Related]
14. Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy.
Camoriano JK; Greipp PR; Bayer GK; Bowie EJ
N Engl J Med; 1987 Apr; 316(18):1133-5. PubMed ID: 3574359
[No Abstract] [Full Text] [Related]
15. Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo.
Kyle RA; Greipp PR
Blood; 1978 Oct; 52(4):818-27. PubMed ID: 356916
[TBL] [Abstract][Full Text] [Related]
16. AL amyloidosis: therapeutic response in two patients with renal involvement.
Goddard IR; Jackson R; Jones JM
Nephrol Dial Transplant; 1991; 6(8):592-4. PubMed ID: 1956560
[No Abstract] [Full Text] [Related]
17. An unusual case of primary systemic amyloidosis.
Ambrosone L; Mansi L; Salvatore T; Marino F; Orabona P; Rambaldi A; Rambaldi PF; Rambaldi M
J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):53-7. PubMed ID: 9552758
[TBL] [Abstract][Full Text] [Related]
18. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
[TBL] [Abstract][Full Text] [Related]
19. [Follicular mucinosis with generalized para-amyloidosis as a cutaneous paraneoplastic syndrome in myeloma (IgD and light chain plasmacytoma). A demonstration of the course using melphalan-prednisone therapy with a 3 years remission].
Jänner M; Lippert HD; Stolzenbach G
Z Hautkr; 1977 Aug; 52(16):873-40. PubMed ID: 408988
[No Abstract] [Full Text] [Related]
20. [Therapy options in systemic AL-amyloidosis with renal involvement].
Hetzel GR; Schneider P; Mondry A; Heering P; Heyll A; Grabensee B
Dtsch Med Wochenschr; 2000 Aug; 125(34-35):997-1002. PubMed ID: 11004911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
